Lattanzi, Simona http://orcid.org/0000-0001-8748-0083
Trinka, Eugen
Zaccara, Gaetano
Striano, Pasquale
Del Giovane, Cinzia
Silvestrini, Mauro
Brigo, Francesco
Article History
First Online: 26 August 2020
Declarations
:
: Open access funding provided by Università Politecnica delle Marche within the CRUI-CARE Agreement. No funding has been received for the conduct of this study.
: Simona Lattanzi has received speaker’s or consultancy fees from Eisai, UCB Pharma, and GW Pharmaceuticals and has served on an advisory board for GW Pharmaceuticals. Eugen Trinka received speaker’s honoraria from UCB Pharma, Biogen, Gerot-Lannach, Bial, Eisai, Takeda, Newbridge, Sunovion Pharmaceuticals Inc., LivaNova, and Novartis; consultancy funds from UCB Pharma, Biogen, Gerot-Lannach, Bial, Eisai, Takeda, Newbridge, GW Pharmaceuticals, Sunovion Pharmaceuticals Inc., and Novartis; and directorship funds from Neuroconsult GmbH. E. Trinka’s institution received grants from Biogen, Red Bull, Merck, UCB Pharma, European Union, FWF Österreichischer Fond zur Wissenschaftsförderung, and Bundesministerium für Wissenschaft und Forschung. Gaetano Zaccara received speaker’s or consultancy fees from Eisai, Sanofi-Aventis, and UCB Pharma. Pasquale Striano received fees and research grants from GW Pharmaceuticals, Zogenyx, Biomarin, and Kolfarma s.r.l. Cinzia Del Giovane and Mauro Silvestrini have no conflicts of interest directly relevant to the content of this study. Francesco Brigo acted as a consultant for Eisai.
: All authors approved the final manuscript for submission.
: SL drafted the concept, analyzed data, and wrote the manuscript. SL and GZ performed the literature search. ET, GZ, PS, CDG, MS, and FB critically revised the work. All authors contributed to the final manuscript.